Vista AI Secures $29.5 Million in Series B Funding to Expand Automated MRI Platform
Vista AI, Inc., a leader in automated MRI scanning software, has announced the successful closing of $29.5 million in Series B financing, a funding round that drew participation from notable health systems including Cedars-Sinai Health System, Intermountain Health, and Tampa General Hospital. The financing will enable the company to further develop its platform, which aims to alleviate the critical shortage of MRI technologists by automating the scanning process.
The company’s FDA-cleared software has been designed to tackle the pressing issue of technologist shortages, enhancing scan capacity while simultaneously reducing backlogs and scan times. “Radiology is facing a critical bottleneck: demand for MRI far outstrips the supply of skilled technologists, overburdening staff and forcing delays for patients,” stated Daniel Hawkins, CEO of Vista AI. “Vista AI is breaking through that barrier by automating the scanning process, enabling technologists to consistently and efficiently deliver high-quality imaging, regardless of location.”
The new funding will facilitate an expansion into additional anatomies, including brain, prostate, and spine MRIs, following FDA clearance. This marks a significant step towards creating a comprehensive platform for automated MRI delivery. By extending its services to include remote scanning, Vista AI aims to allow facilities lacking cardiac MRI expertise to offer high-quality imaging to their patients.
Vista AI’s impact has already been felt at various health organizations. At Brigham and Women’s Hospital, the platform enabled a 50% increase in cardiac MRI scan slots, effectively eliminating a 28-day backlog and supporting next-day patient access without the need for additional staff or extended operating hours. Similarly, at Radiology Regional, an imaging chain in Southwest Florida, the automated system reduced scan times by more than 50%, empowering technologists with no prior cardiac MRI experience to deliver exams confidently.
Health system leaders have highlighted the significance of this automation in improving patient care. “Consistency in imaging quality translates directly into better patient care, and we are now able to provide that consistent standard of excellence across our system,” remarked Maureen Burgess, Partner at Cedars-Sinai Health Ventures. Dr. Blake Gardner, Senior Medical Director of Cardiovascular Clinical Program at Intermountain Health, emphasized, “With demand rising and technologists in short supply, automation is the only way forward. Vista AI can extend advanced imaging beyond our main centers and make MRI accessible to more patients across our network.”
Investors also underscored the broader implications of Vista AI’s technology. Bruce Armstrong, Partner at Khosla Ventures, noted, “MRI is the backbone of modern diagnosis, yet access is constrained by workforce shortages and complexity. Vista AI is the only company directly addressing this issue with automation. That’s why leading health systems are investing—because Vista AI is on the path to becoming essential infrastructure in radiology.”
Hawkins remarked on the transformative potential of the company’s technology, stating, “With this financing, we are not just scaling a company, we are scaling access to gold-standard diagnostic capability. By combining our automated MRI scanning software with remote scanning services, we can help healthcare organizations reduce backlogs, ease staff burden, and deliver consistently high-quality imaging to more patients than ever before.”
As Vista AI continues its expansion and further integrates automation into the healthcare landscape, the company aims to address the pressing need for efficient and accessible medical imaging. For more information about Vista AI’s offerings, interested parties can visit vista.ai/demo.
About Vista AI
Vista AI is pioneering AI-powered MRI automation, committed to making advanced imaging universally accessible. Its FDA-cleared cardiac MRI platform enables technologists to deliver high-quality imaging consistently and efficiently. With ongoing expansion into additional anatomies and remote scanning services, Vista AI is reshaping the future of automated MRI scanning, aiming to scale healthcare delivery and enhance patient access. The company is backed by prominent investors, including Khosla Ventures and leading U.S. health systems. To learn more, visit vista.ai.
Media Contact
Nicole Winokur
Vice President, Marketing
[email protected]
Quantum Computing Market Projected to Surge to $72 Billion by 2035, Says McKinsey
Tesseract Launches Site Manager and PRISM Vision Badge for Job Site Clarity
Affordable Android Smartwatches That Offer Great Value and Features
Russia”s AIDOL Robot Stumbles During Debut in Moscow
AI Technology Revolutionizes Meat Processing at Cargill Slaughterhouse
